IMM-1811900

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIMM-1811900
Drug Alias Namepan-KRAS inhibitor (Immuneering)IMM-1811900
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmuneering Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuneering Corp
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A